Avoro Capital Advisors LLC - 31 Dec 2024 SCHEDULE 13G/A Report for Vera Therapeutics, Inc. Class A Common Stock, $0.001 par value per share (VERA)

Filing Manager
Avoro Capital Advisors LLC
Reporting Manager
Avoro Capital Advisors LLC
Security
Vera Therapeutics, Inc. Class A Common Stock, $0.001 par value per share
Symbol
VERA
Shares outstanding
63,033,708 shares
Disclosed Ownership
5,610,000 shares
Ownership
8.9%
Form type
SCHEDULE 13G/A
Filing time
14 Feb 2025, 09:30:55 UTC
Date of event
31 Dec 2024
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Avoro Capital Advisors LLC disclosed 8.9% ownership in Vera Therapeutics, Inc. Class A Common Stock, $0.001 par value per share (VERA) on 31 Dec 2024."

Quick Takeaways

  • Avoro Capital Advisors LLC filed SCHEDULE 13G/A for Vera Therapeutics, Inc. Class A Common Stock, $0.001 par value per share (VERA).
  • Disclosed ownership: 8.9%.
  • Date of event: 31 Dec 2024.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 14 Feb 2025, 09:30.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Avoro Capital Advisors LLC 8.9% 5,610,000 5,610,000 0 /s/ Scott Epstein Scott Epstein, Chief Financial Officer & Chief Compliance Officer
Behzad Aghazadeh 8.9% 5,610,000 5,610,000 0 /s/ Behzad Aghazadeh Behzad Aghazadeh, Individually

Sponsored